Ardsley Advisory Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$19.9M |
| 2 |
T-Mobile US
TMUS
|
+$17.2M |
| 3 |
AbbVie
ABBV
|
+$12.5M |
| 4 |
Lumentum
LITE
|
+$11.5M |
| 5 |
Qualcomm
QCOM
|
+$10.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$8.88M |
| 2 |
FTAI Aviation
FTAI
|
+$8.81M |
| 3 |
STAAR Surgical
STAA
|
+$8.17M |
| 4 |
Sunrun
RUN
|
+$6.51M |
| 5 |
ZEN
ZENDESK INC
ZEN
|
+$6.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.99% |
| 2 | Healthcare | 17.02% |
| 3 | Consumer Staples | 13.31% |
| 4 | Industrials | 11.19% |
| 5 | Consumer Discretionary | 7.12% |
Similar funds
Ardsley Advisory Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Ardsley Advisory Partners held 180 positions worth $470M, up 84% from $255M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Ardsley Advisory Partners deployed $84.2M of net new capital in Q2 2020, opening 79 new positions and adding to 20 existing holdings. Its largest new stake was T-Mobile US: 179,510 shares worth $18.7M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was State Street SPDR S&P Biotech ETF, an estimated $8.88M trimmed.
- Ardsley Advisory Partners's largest Q2 2020 buy was T-Mobile US: 179,510 shares worth $18.7M.
- Ardsley Advisory Partners added most to Microsoft in Q2 2020, an estimated $19.9M increase.
- Ardsley Advisory Partners's biggest Q2 2020 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $8.88M.
- Ardsley Advisory Partners fully exited ZENDESK INC in Q2 2020, selling an estimated $6.08M.
- Ardsley Advisory Partners's ten largest holdings make up 50% of its $470M portfolio in Q2 2020.
- Ardsley Advisory Partners opened 79 new positions and closed 47 in Q2 2020.
- Ardsley Advisory Partners's portfolio value rose 84% quarter-over-quarter to $470M.
Based on Ardsley Advisory Partners's 13F filing for Q2 2020, filed 14 Aug 2020.